Company Coverage
China Resources Mixc Lifestyle Services (1209 HK): 1H26 Results Preview: In-Line Double-Digit Earnings Growth, Commercial-Led Margin Uplift
BUY (Maintained)
Current price:
Target price:
Upside:
HK$38.84
HK$55.00
+41.6%
Analyst
Analyst
Highlights
- We expect CR Mixc's 1H26 results to be in line with estimates, with core net profit maintaining double-digit yoy growth and revenue up by high single digits yoy, slightly below profit growth. Gross margin is expected to edge up, led by the commercial segment.
- Mall retail sales rose by high double digits yoy in 1H26 (same-store: high single digit), with luxury malls outperforming. The company plans to open 12 new malls this year (10 in 2H26) and sign 20 new malls in 2026.
- VAS revenue is still expected to decline yoy, but the pace of decline should narrow. We expect dividend policy to remain unchanged at a 100% payout (60% regular + 40% special), We expect 1H26 OCF to remain seasonally low, with the interim OCF/core net profit ratio at 60-70%, while the full-year ratio is expected to remain above 1.0x. Maintain BUY. Target price: HK$55.00.
Analysis
- 1H26 on track with double-digit profit growth intact. We expect China Resources Mixc Lifestyle Services’ (CR Mixc) 1H26 results to be in line with its full-year target of double-digit net profit growth. We expect total revenue to grow at a high single-digit pace, slightly below profit growth, while gross profit margin should edge up modestly, led by the commercial segment. Overall, the property management segment is expected to provide stable revenue growth, and the commercial business should be the main growth and margin driver.
- Shopping mall business should remain resilient. We expect total retail sales across CR Mixc malls to have grown by high double digits yoy in 1H26, with same-store sales (SSS) up by high single digit yoy and luxury malls outperforming the overall portfolio. In June alone, overall retail sales grew mid-single digit yoy while SSS dipped slightly, dragged by auto sales (a fixed-rent format that affects retail sales only). On new mall openings, we expect the company to open 12 new malls in 2026. We estimate that two malls were opened in 1H26, leaving the rest to be opened in 2H26. On mall expansion, it secured seven third-party projects in 1H26, and parent CR Land contributed five malls. We expect CR Mixc to sign 20 new malls in 2026 (vs 13 malls in 2025).
Highlights
- We expect CR Mixc's 1H26 results to be in line with estimates, with core net profit maintaining double-digit yoy growth and revenue up by high single digits yoy, slightly below profit growth. Gross margin is expected to edge up, led by the commercial segment.
- Mall retail sales rose by high double digits yoy in 1H26 (same-store: high single digit), with luxury malls outperforming. The company plans to open 12 new malls this year (10 in 2H26) and sign 20 new malls in 2026.
- VAS revenue is still expected to decline yoy, but the pace of decline should narrow. We expect dividend policy to remain unchanged at a 100% payout (60% regular + 40% special), We expect 1H26 OCF to remain seasonally low, with the interim OCF/core net profit ratio at 60-70%, while the full-year ratio is expected to remain above 1.0x. Maintain BUY. Target price: HK$55.00.
Analysis
- 1H26 on track with double-digit profit growth intact. We expect China Resources Mixc Lifestyle Services’ (CR Mixc) 1H26 results to be in line with its full-year target of double-digit net profit growth. We expect total revenue to grow at a high single-digit pace, slightly below profit growth, while gross profit margin should edge up modestly, led by the commercial segment. Overall, the property management segment is expected to provide stable revenue growth, and the commercial business should be the main growth and margin driver.
- Shopping mall business should remain resilient. We expect total retail sales across CR Mixc malls to have grown by high double digits yoy in 1H26, with same-store sales (SSS) up by high single digit yoy and luxury malls outperforming the overall portfolio. In June alone, overall retail sales grew mid-single digit yoy while SSS dipped slightly, dragged by auto sales (a fixed-rent format that affects retail sales only). On new mall openings, we expect the company to open 12 new malls in 2026. We estimate that two malls were opened in 1H26, leaving the rest to be opened in 2H26. On mall expansion, it secured seven third-party projects in 1H26, and parent CR Land contributed five malls. We expect CR Mixc to sign 20 new malls in 2026 (vs 13 malls in 2025).
BUY (Maintained)
Current price:
Target price:
Upside:
HK$38.84
HK$55.00
+41.6%
Analyst
Analyst
IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at the following link: https://research-api.uobkayhian.com/assets/disclaimer/df64a6ea-7980-447c-ae9e-fd19b93257dc, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.
Related articles
Company Coverage
24 Jul 2026
Sino Biopharmaceutical (1177 HK): Innovation Continues To Fuel Growth
Company Coverage
24 Jul 2026
Baidu Inc (9888 HK) 2Q26 Results Preview: AI Cloud Growth Offset by Advertising Weakness; Strategic Catalysts In Focus
Company Coverage
23 Jul 2026
Link REIT (823HK): Disposal Of 50% Stake In 100 Market Street Enhances Flexibility For Buyback And Reinvestment
Our latest research
Company Coverage
24 Jul 2026
TA: Xiaomi (1810 HK) / Sino Biopharmaceutical (1177 HK)
Company Coverage
24 Jul 2026
Sino Biopharmaceutical (1177 HK): Innovation Continues To Fuel Growth
Company Coverage
24 Jul 2026